• 17 July, 2018
  • The ISSCR 2018 Annual Meeting went “down under” to Melbourne, Australia where 3,000 stem cell scientists, clinicians, and professionals from 52 countries gathered to share their latest research, network with colleagues, and explore the latest technologies driving the field forward.
    Full story
  • 22 June, 2018
  • The ISSCR is pleased to announce Douglas A. Melton, PhD, Harvard University, as the incoming president of the ISSCR and its board of directors. Melton assumed the post on 23 June, 2018, immediately following the 16th ISSCR Annual Meeting in Melbourne, Australia.
    Full story
  • 20 June, 2018
  • The ISSCR has appointed Martin F. Pera, professor at the Jackson Laboratory, U.S., as the next editor-in-chief of Stem Cell Reports, the organization’s open-access journal. Pera will succeed Christine Mummery, who led the journal since its launch in 2013. Pera will assume the post in January, 2019.
    Full story
  • 14 June, 2018
  • 6/14/2018 2:00:00 PM

    The ISSCR opposes the U.S. House of Representatives proposal to ban federal funding for fetal tissue research. ISSCR President Hans Clevers released a statement on the issue.
    Full story
  • ISSCR Announces Hamburg, Germany as Site of 2021 Annual Meeting

  • 23 May, 2018
  • The ISSCR will hold its 2021 annual meeting in Hamburg, Germany, the first time the organization will be meeting in that city. The meeting is expected to draw 4,000 stem cell researchers and professionals from around the globe to the Congress Center Hamburg, scheduled to open in 2019. The meeting will be held 23-26 June, 2021.
    Full story
  • ISSCR Responds to President Trump Signing 'Right to Try' Law

  • 4 June, 2018
  • 6/4/2018 4:00:00 AM

    The ISSCR is disappointed with the enactment of the ‘Right to Try’ law. Along with more than 100 patient and research groups opposing the bill, we believe it will put patients at risk and undermine the effective FDA Expanded Access Program already in place to give seriously ill patients access to experimental treatments.
    Full story
  • ISSCR Applauds Federal Injunctions Against Stem Cell Clinics

  • 10 May, 2018
  • The ISSCR is pleased that federal prosecutors in the U.S. have taken action to halt the marketing and delivery of unproven stem cell treatments at clinics they allege are operating outside of FDA regulation.
    Full story
  • Active Support for Stem Cell Research Around the World

  • 7 May, 2018
  • Scientific progress requires that legislators and regulators around the world recognize and appreciate the value of research and actively support pro-science policies. The ISSCR, through its policy program, champions the advancement of stem cell research and its translation to medicine.
    Full story
  • ISSCR 2018 to Highlight Research Driving New Discoveries and Advances in Regenerative Medicine

  • 30 April, 2018
  • Progress in stem cell research and its translation to medicine is the focus of the International Society for Stem Cell Research annual meeting 20-23 June at the Melbourne Convention & Exhibition Centre in Melbourne, Australia.
    Full story
  • ISSCR Advocates for Stem Cells and Basic Research in Europe

  • 19 April, 2018
  • ISSCR members and staff met 12 April with the European Parliament’s Committee on Industry, Research and Energy to advocate for investments in basic research in the European Union’s 9th Framework Programme for Research and Innovation.
    Full story
  • Collaborations for Improving Human Health

  • 9 April, 2018
  • Like many stem cell researchers, my work is increasingly focused on developing ways to translate basic scientific discovery into treatments that help people suffering from disease or injury. The potential for stem cell therapies initially fascinated me as a developmental biologist, and over time I’ve learned the very real impact that our science can have on human health.
    Full story
  • ISSCR Advocates for Science Investment in Letter to European Commission

  • 3 April, 2018
  • In a letter to the European Commission today, the ISSCR encourages the EU to spur innovation by supporting basic research and programs that foster cooperation among fundamental research endeavors across Europe.
    Full story
  • ISSCR Announces Recipients of 2018 Awards

  • 14 March, 2018
  • Recipients of the 2018 awards will be presented at the society’s annual meeting, 20-23 June in Melbourne, Australia: ISSCR Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award.
    Full story
  • 'Right to Try' Legislation in U.S. House of Representatives is Narrowly Defeated; ISSCR Opposed

  • 12 March, 2018
  • The legislation would have put patients at risk, slowed the development of effective stem cell therapies, and blocked the Food and Drug Administration (FDA) from access to crucial data about the safety and effectiveness of new medical treatments.
    Full story
  • ISSCR 2018 Election Results

  • 12 March, 2018
  • The ISSCR is pleased to announce the results of its 2018 leadership election. On behalf of all members, we extend congratulations to newly-elected officers and board members.
    Full story
  • Scientific Excellence at ISSCR 2018

  • 12 March, 2018
  • Scientific excellence is at the core of the ISSCR and is reflected each year in the annual meeting, where exceptional science is shared, discussed, and deliberated. This exchange is key to advancing the scientific dialogue that moves the field forward. The 2018 program in Melbourne, Australia continues that tradition, featuring groundbreaking research presented in plenary, concurrent, and poster sessions.
    Full story
  • ISSCR Releases Guidebook to Evaluate Cell Therapy Trials

  • 15 February, 2018
  • The ISSCR is pleased to announce the release of “Stem Cell Based Clinical Trials: Practical Advice for Physicians and Ethics / Institutional Review Boards,“ a guidebook providing background and fundamental questions for clinicians and review boards to ask when considering running or reviewing early phase, cell-based clinical trials. The guide was developed by practicing physician-scientists and stem cell professionals on the ISSCR’s Clinical Translation Committee.
    Full story
  • Showcasing Inspiring Science and Natural Beauty

  • 9 February, 2018
  • There is no better host city for the ISSCR 2018 annual meeting than Melbourne, Australia, a global hub of innovation in science and biotech with a rich stem cell history, flourishing research culture, and inspiring natural beauty and art.
    Full story
  • ISSCR Remembers Hiromitsu “Hiro” Ogawa

  • 4 January, 2018
  • The ISSCR is saddened by the passing of Hiromitsu “Hiro” Ogawa, a generous and thoughtful man who was a great supporter of stem cell science and the ISSCR.
    Full story
  • ISSCR Announces New Policy Director, Eric Anthony

  • 11 December, 2017
  • The ISSCR has named Eric Anthony to be its new Director of Policy. Anthony served more than eight years as staff in the U.S. Congress, most recently as legislative director for Congresswoman Rosa DeLauro of Connecticut. He will join the Society in early January 2018.
    Full story
    View All ISSCR News